Analyst firms · Guggenheim · DT
Guggenheim DT price target and rating history
Dynatrace Inc. (DT) · Technology
Guggenheim rates Dynatrace Inc. (DT) Neutral with a $66 price target, as of its latest action on May 13, 2026. It has published 4 rating actions on DT since October 2023, including 1 upgrade and 2 downgrades. Across 10 firms with a DT price target in the last 12 months, the median target is $61.
- Current rating
- Neutral
- Price target
- $66
- Median target, all firms
- $61
- Actions on DT
- 4
Guggenheim price target on DT
Every Guggenheim rating on DT
- May 13, 2026
- Jul 23, 2025
- Jan 6, 2025
- Oct 23, 2023
How other firms rate DT
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| BNP Paribas Exane | Outperform | $75 | Oct 8, 2026 |
| Oppenheimer | Outperform | $71 | Sep 24, 2026 |
| Needham | Buy | $68 | Sep 18, 2026 |
| BMO Capital Markets | Outperform | $62 | Sep 15, 2026 |
| Wedbush | Neutral | $54 | Sep 11, 2026 |
| Morgan Stanley | Overweight | $65 | Aug 25, 2026 |
| UBS | Buy | $60 | Jun 16, 2026 |
| William Blair | Outperform | May 21, 2026 | |
| Guggenheim | Neutral | May 13, 2026 | |
| Rothschild & Co Redburn | Neutral | $40 | Apr 23, 2026 |
| Goldman Sachs | Buy | $45 | Apr 21, 2026 |
| Macquarie | Neutral | $36 | Feb 27, 2026 |
Questions about Guggenheim and DT
- What is Guggenheim's price target for DT?
- Guggenheim's latest stated price target for Dynatrace Inc. (DT) is $66, from its action on Jul 23, 2025.
- What is Guggenheim's rating on DT?
- Guggenheim rates DT Neutral, a neutral rating, as of May 13, 2026.
- When did Guggenheim last change its view on DT?
- On May 13, 2026, Guggenheim downgrades to Neutral from Buy.
- How does Guggenheim's DT target compare with other analysts?
- Across 10 firms with a DT price target in the last 12 months, the median target is $61.
More DT rating histories
All Guggenheim ratingsDT news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.